12 Jun PeerVoice – Advances in Adjuvant Melanoma Therapy
We are pleased to announce that the PeerVoice activity entitled ”Advances in Adjuvant Melanoma Therapy: Working Together To Improve Outcomes’’ has now launched online. SYSF is proud to endorse this work, and applauds the valuable work put into this educational resource.
Michael Smylie, MBCHB, FRCPC, Edmonton, Alberta
Joël Claveau, MD, FRCPC, Quebec City, Quebec
Carolyn Nessim, MD, MSc, FRCSC, FACS, Ottawa, Ontario
Presentation 1: Adjuvant Melanoma Therapy: Optimizing the Care Pathway
Presentation 2: Adjuvant Melanoma Therapy: Experts Appraise the Evidence
These verbal interview-style presentations are also available as downloadable transcripts, click here to view or read the presentations: PeerVoice: Advances in Adjuvant Melanoma Therapy
PeerVoice activities are designed to fill the unmet needs of the medical community by reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. This independent learning activity is supported by Merck Canada Inc.
NEW! December 2019: Minding the Melanoma Patient With Brain Metastases: Updates to Personalize Care
Listen to the recording, and/or download the presentation, by:
Marcus Butler, Medical Oncologist, University of Toronto | Princess Margaret Cancer Centre
Raising the Bar With Immunotherapy for Melanoma and Kidney Cancer: Strategies to Enhance Care. This independent learning activity is funded by Bristol-Myers Squibb Canada Co.